Search

Your search keyword '"Demuth, H.-U."' showing total 98 results

Search Constraints

Start Over You searched for: Author "Demuth, H.-U." Remove constraint Author: "Demuth, H.-U."
98 results on '"Demuth, H.-U."'

Search Results

53. Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats.

55. Dipeptidyl Peptidase IV in Human T Lymphocytes Impaired Induction of Interleukin 2 and Gamma Interferon Due to Specific Inhibition of Dipeptidyl Peptidase IV.

56. Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide.

59. Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs.

60. 35th Annual Meeting of the European Association for the Study of Diabetes

61. Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes

62. Dipeptidylpeptidase Iv - Inactivation with N-Peptidyl-O-Aroyl Hydroxylamines

63. Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines

64. 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999

65. 40 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

70. Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (betaTC-3) cells to glucose-dependent insulinotropic polypeptide.

71. Kinetic analysis of enzymatic and nonenzymatic degradation of peptides by MALDI-TOFMS.

72. Analogs of glucose-dependent insulinotropic polypeptide with increased dipeptidyl peptidase IV resistance.

73. Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide.

74. Effects of the CLIP fragment ACTH 20-24 on the duration of REM sleep episodes.

75. Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel kinetic approach.

76. N-peptidyl, O-acyl hydroxamates: comparison of the selective inhibition of serine and cysteine proteinases.

77. Nature of the inactivation of elastase by N-peptidyl-O-aroyl hydroxylamine as a function of pH.

78. Inactivation of subtilisin Carlsberg by N-((tert-butoxycarbonyl)alanylprolylphenylalanyl)-O-benzoylhydroxyl- amine: formation of a covalent enzyme-inhibitor linkage in the form of a carbamate derivative.

80. Enzymatic activity of CD26 (dipeptidylpeptidase IV) is not required for its signalling function in T cells.

81. Inhibition of dynorphin converting enzymes from human spinal cord by N-peptidyl-O-acyl hydroxylamines.

82. Novel N-peptidyl-O-acyl hydroxamates: selective inhibitors of cysteine proteinases.

83. Peptidyl ammonium methyl ketones as substrate analog inhibitors of proline-specific peptidases.

84. Relationship between primary structure and activity in exorphins and endogenous opioid peptides.

85. Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytes.

86. Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes.

87. Studies of specificity and inhibition of human cerebrospinal fluid dynorphin converting enzyme.

88. Inhibition of proteases with enkephalin-analogue inhibitors.

89. Recent developments in inhibiting cysteine and serine proteases.

90. Contamination of highly purified human serum cholinesterase by dipeptidyl peptidase IV causing hydrolysis of substance P.

91. Reactions between dipeptidyl peptidase IV and diacyl hydroxylamines: mechanistic investigations.

92. The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes.

93. The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro.

94. Molecular interactions in intermediate and transition states in the self-stimulated inhibition of enzymes.

95. N,O-diacylhydroxylamines as enzyme-activated inhibitors for serine proteases.

96. Potent and selective inactivation of proteinases with N-peptidyl-O-acylhydroxylamines.

97. Enzymic properties of intestinal aminopeptidase P: a new continuous assay.

Catalog

Books, media, physical & digital resources